Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
1999 Providing a treatment for Respiratory Distress Syndrome in children, Amarey launches a pulmonary surfactant for newborns with positive effects on the baby’s tranquility.
2006 The desire to fulfill the dream of one father and to overcome difficult circumstances gives birth to OCMAES, a foundation which promotes education in accredited universities for Colombian youngsters with high academic potential.
2009 Amarey introduces reconstruction products and state-of-the-art implants that help patients have a more active and satisfying life to the the Colombian market.
2009 Amarey is recognized by Stryker with the First Place in Implant Distribution and as one of the 10 best distribution companies for Latin America.
2011 Ucipharma is recognized with the first place in Latin American Sales of Hartmann Products.
Genomic Health Company honors Amarey Nova Medical with the “International Sales Award 2013”.
2014 The National Government grants Amarey Nova Medical the Colombian Management Quality Award 2014, demonstrating the ability to deliver a value offering that is clearly differentiated and outstanding in quality.
2016 Portfolio Awards awards an honorable mention to Amarey Nova Medical in the Customer Service Category.
Rate GRUPO AMA's efforts to communicate its history to employees.
Do you work at GRUPO AMA?
Does GRUPO AMA communicate its history to new hires?
Zippia gives an in-depth look into the details of GRUPO AMA, including salaries, political affiliations, employee data, and more, in order to inform job seekers about GRUPO AMA. The employee data is based on information from people who have self-reported their past or current employments at GRUPO AMA. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by GRUPO AMA. The data presented on this page does not represent the view of GRUPO AMA and its employees or that of Zippia.
GRUPO AMA may also be known as or be related to GRUPO AMA and Grupo Ama.